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Abstract: This review compiles the advances achieved in our laboratories using abnormal and less heteroatom-
stabilized carbenes as ligands for transition metal chemistry. Fundamental studies allowed the evaluation of the 
impact of this new class of ligands both electronically and sterically. Based on these results, initial catalytic appli-
cations have been devised in the area of H–H and C–H bond activation, demonstrating the potential of abnormal 
carbenes as unique ligands for transition metals. 
Keywords: Abnormal coordination mode · Catalytic applications · N-Heterocyclic carbenes · 
Late transition metals · Metal nucleophilicity
Martin Albrecht 
studied chemistry 
at the University of 
Bern and received 
his PhD under the 
supervision of Ge-
rard van Koten from 
Utrecht University 
(The Netherlands). 
After postdoctoral 
work with Robert H. 
Crabtree (Yale) and with Ciba SC (Basel), 
he was awarded an Alfred Werner Assis-
tant Professorship, which allowed him to 
initiate his independent research program 
at the University of Fribourg. His current 
interests are in (bio)organometallic chem-
istry in general, with special emphasis on 
developing novel carbene ligands for cata-
lytic and electronic applications. He has 
recently received a Starting Grant from 
the European Research Council to explore 
new twists in this area.
1. Introduction
The discovery of N-heterocyclic carbenes 
(NHCs) as versatile ligands for transition 
metals constitutes one of the most influ-
ential developments in organometallic 
chemistry of the last decade.[1] Research 
has been stimulated in a number of areas 
in materials science and remarkable ad-
vances have been made in fabricating new 
components for light-emitting diodes[2]
and electronic devices.[3] By far the most 
impressive results have been obtained 
undoubtedly in the development of new 
catalytic systems.[4] Some metal NHC 
complexes are extremely powerful cata-
lysts, perhaps most evidently illustrated 
by Grubbs’ second-generation olefin me-
tathesis catalyst,[5] or by the palladium 
NHC complexes introduced by Organ and 
currently commercialized by Aldrich as 
cross-coupling catalysts.[6] The catalytic 
activity of these complexes is extraordi-
narily high, often surpassing the ubiqui-
tous phosphine analogs in homogeneous 
transformations. The outstanding perfor-
mance of NHC complexes has been gener-
ally attributed to the strong M–CNHC bond 
and to the high donor ability of carbene 
ligands. Notably, electron donation of the 
carbene ligand may be further enhanced 
upon displacing or removing one or both 
heteroatoms adjacent to the carbene. From 
a historical perspective, such heteroatom 
engineering has been less considered, as 
the popularity of NHCs has relied by and 
large on the stability of the free carbene.[7]
The availability of free carbenes has 
opened a straightforward access to transi-
tion-metal chemistry, as ligand coordina-
tion with carbenes is comparable to the 
bonding of other neutral donor ligands 
to a metal center, with the exception that 
in carbene chemistry metal–ligand bonds 
are kinetically essentially inert.
The limitations in carbene chemistry in 
terms of presence and location of hetero-
atoms has lately been overcome indepen-
dently by two different approaches. Pre-
dominantly through the pioneering work 
of Bertrand and coworkers, a variety of 
free carbenes with reduced heteroatom sta-
bilization have been shown to be stable.[8]
Crystal structures and coordination prop-
erties have been disclosed for cyclic and 
acyclic carbenes with only one heteroatom 
adjacent to the carbene, or none at all as 
in cyclopropylidene or a recently reported 
allene.[9] In parallel to these achievements, 
new methodologies for the metallation of 
imidazolium salts have been developed 
that avoid the formation of free carbenes. 
Protocols include in particular direct met-
allation via C–H bond activation, trans-
metallation, oxidative C–X and C–H ad-
dition, and formation of the carbene at the 
metal by alkylation of the corresponding 
anionic azolyl ligand.[10] As a direct conse-
quence of these developments, the stability 
of the free carbene is now only of minor 
relevance to the formation of metal NHC 
complexes.
Rather serendipitously, efforts in these 
directions uncovered that metallation may 
occur at positions different from the ex-
pected one (Scheme 1).[11] In imidazolium 
salts, the C(2)-bound proton has by far the 
largest acidity[12] and is therefore generally 
considered to be easiest to activate.[13] How-
ever, with iridium precursors, evidence has 
been provided that in some cases, the C(4) 
position may be more susceptible to metal-
lation than the C(2) position, hence leading 
to abnormal carbene bonding.[14] While the 
terms ‘normal’ and ‘abnormal’ have initial-
ly been used to differentiate between the 
supposedly more stabilized (normal) C(2) 
and the C(4) position, this terminology has 
recently been expanded to the general area 
of NHC chemistry.[15] Thus, a normal car-
bene refers to a carbene, for which a neutral 
canonical resonance form can be drawn, 
while an abnormal carbene requires the in-
troduction of either charges or diradicals in 
the carbene-type resonance form (Scheme 
2). With this broader definition, a range of 
abnormal carbene ligands are conceivable 
(Fig. 1),[15] and many of these have been 
studied as ligands for transition metals, yet 
only in one case, a free abnormal carbene 
has been isolated and characterized by X-
ray diffraction.[9]
Our own interest in using such abnor-
mal carbenes as ligands for catalytically 
active metal centers has been stimulated 
predominantly by the fact that these li-
gands should be extraordinarily strong do-
nors, significantly stronger than their nor-
mal analogs, which are considered as being 
amongst the strongest donor ligands known 
to date. Exceptional donor properties are 
surmised since the inductive electron-
withdrawing effects of the heteroatoms 
are less prevalent if only one heteroatom is 
placed adjacent to the carbene. This report 
summarizes our advances in this area and 
includes first catalytic applications arising 
from the unique bonding properties of ab-
normal carbene ligands.
2. Abnormal Imidazolylidene 
Complexes
In order to direct metallation to the 
C(4) position of imidazolium salts,[16] two 
general strategies appear to be particularly 
useful:[17] i) activation of the C(4) position, 
and ii) deactivation of the generally more 
reactive C(2) position.
2.1 Metallation via Activation of the 
Imidazolium C(4) Position
Incorporation of a halide at the imida-
zole C(4) position and subsequent alkyla-
tion and quaternization of the nitrogen cen-
ters provides imidazolium salts for oxida-
tive addition to a low valent metal center. 
We have demonstrated the feasibility of 
this approach by starting from 4-iodoimi-
dazole 1, which has been regioselectively 
N-alkylated and subsequently quaternized 
with a chelating donor group. Oxidative 
addition to palladium(0) affords complex 
3 comprising a chelating C(4)-bound imi-
dazolylidene ligand (Scheme 3).[18] Vari-
able temperature analysis has shown that 
the abnormal bonding mode is thermally 
stable at least up to 100 °C. No rearrange-
ment to the presumably thermodynami-
cally more stable C(2)-bound isomer has 
been detected. Current investigations in 
our laboratories indicate that this haloge-
nation/oxidative addition methodology can 
be expanded to the synthesis of a variety of 
different abnormal carbene complexes,[19]
thus providing a general access to this class 
of ligands.
2.2 Metallation via Deactivation of 
the Imidazolium C(2) Position
Protection of the imidazolium C(2) po-
sition provides an alternative methodology 
to the activation protocol in order to direct 
metallation to the imidazolium C(4) posi-
tion. Efficient blocking of the C(2) carbon 
has been accomplished by introducing an 
alkyl or an aryl group. A number of 2-al-
kylated and 2-arylated imidazoles are com-
mercially available or readily accessible by 
simple synthetic protocols, thus providing 
a straightforward feedstock for this type of 
ligand precursors. Substitution effectively 
blocks the C(2) position and generally 
directs metallation to the C(4) position. 
Notably, alkylation of the C(2) position 
is not always reliable and under certain 
conditions, activation of an exocyclic 
C(sp3)–H bond may be competitive with 
C(4)–H bond activation. Such reactions 
have been observed with strong bases, in-
cluding Ag2O and with iridium precursors, 
and may yield the corresponding exocyclic 
olefin, a metal-alkyl complex, or even lead 
to C–C bond breaking and normal imida-
zolylidene coordination.[20]
Such undesired reaction trajectories 
are suppressed, either by protecting the 
C(2) position with an aryl group, i.e. with 
a group lacking _ hydrogens, or by direct 
C–H bond activation using a mildly basic 
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Fig. 1. Selection of abnormal and normal 
heterocyclic carbene ligands bound to a metal 
center. For the sake of clarity, the normal 
carbene complexes are represented by 
M = C double bonds, though the bonding 
differences between normal and abnormal 
carbenes to metals is assumed to be less 
pronounced than the drawing here may imply.
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Scheme 3.
abnormal C(4) bonding of the carbenes 
markedly increases the nucleophilicity of 
the coordinated metal center as compared 
to C(2) bonding. Despite its formal +2 
charge, the palladium center in these com-
plexes is best described as a Lewis base. 
The abnormal carbene bonding mode in-
duces new reaction patterns such as the 
formation of a stable and crystallographi-
cally characterized Pd–Ag adduct.[23,25]
Some of the reactivity differences of 
normal and abnormal imidazolylidene 
complexes may, in principle, be a conse-
quence of steric differences. In particular 
the absence of a wingtip group in ortho po-
sition to the carbene alters the accessibility 
of the coordinated metal center and may 
render the M–CNHC bond more susceptible. 
In addition, in normal carbenes, the steric 
demand of the wingtip groups forces the 
carbene ligand to bend out of the coordi-
nation plane (dihedral angles between pal-
ladium square plane and heterocycles are 
typically around 40°), while in abnormal 
imidazolylidenes containing a hydrogen 
at the C(5) nucleus, the twist tends to be 
much smaller (dihedral angles around 
28°). These geometrical differences influ-
ence the orbital orientation and may hence 
metal precursor. This approach has been 
utilized to prepare different complexes 
containing C(4)-bound imidazolylidene 
ligands.[21] We have extended the method-
ology to cis-coordinating dicarbene sys-
tems. In such chelating ligands, the rota-
tional flexibility of the carbene ligand is 
restricted, which is expected to result in a 
reduced lability of the complex towards re-
ductive elimination. In addition, in square-
planar d8 metal complexes, the remaining 
two positions are labilized as they are both 
trans to a carbene ligand. Therefore, the 
anticipated high trans influence and trans
effect of abnormal carbenes can be ideally 
exploited. In addition, the corresponding 
normal dicarbene complexes are known[22]
and allow for comparative studies.
For example, palladation of the C(2)-
protected diimidazolium salts 4 with 
Pd(OAc)2 affords complexes 5 compris-
ing C(4)-bound diimidazolylidene ligands 
(Scheme 4).[23] The conditions applied 
for this metallation are virtually identi-
cal to those used for the preparation of 
the normal analog, which may suggest 
that C–H bond activation is probably not 
rate-limiting. Based on metallation stud-
ies including the palladation of a dis-
symmetric potentially normal-abnormal 
diimidazolium salt, a rationale for the 
selective activation of the C(4)–H bond 
in the diimidazolium precursor salts has 
been proposed.[24] Thus, formation of a 
palladate [PdX2(OAc)2]2– seems to be fast 
and essential for the subsequent steps. In 
studies using imidazolium salts with non-
coordinating counterions such as BF4– or 
PF6
–
, metallation is suppressed. The palla-
date is supposed to be stabilized by the di-
cationic imidazolium salt in what may be 
best described as an ion pair (A, Scheme 
4). In addition to the electrostatic interac-
tions, further stabilization may arise from 
hydrogen bonding of the acetate oxygen 
with the most acidic hydrogen of the imi-
dazolium salt, viz. C(2)–H in normal and 
C(4)–H in C(2)-protected imidazolium 
cations. Such a hydrogen bond interaction 
weakens the C–H bond and at the same 
time, increases the nucleophilicity of the 
carbon, which is assumed to be a critical 
factor for promoting C...Pd interactions. 
Moreover, such a model rationalizes the 
selectivity observed for C(4)–H rather 
than C(5)–H bond activation in the imi-
dazolium salt 4. In an idealized case, the 
Himi...Oacetate and the C...Pd interactions are 
established in a concerted process, leading 
to a six-membered transition state B. Sub-
sequent loss of HOAc from such a transi-
tion state is easily conceivable and gives 
C. Interestingly, complexes related to C
are resistant towards acidolysis (e.g. using 
HOAc), indicating that the A-to-C trans-
formation is an irreversible process and 
hence not thermodynamically controlled.
Formation of the second C–Pd bond 
from the monocarbene complex C may 
occur according to a similar mechanism, 
though the palladate in C is less anionic 
than in A due to the substitution of an ac-
etate ligand by a heterocyclic carbene. As 
a consequence, the Himi...Oacetate interaction 
may be less pronounced. In normal car-
benes, this reduced activity may be com-
pensated by the relatively high acidity of 
the C(2)-bound proton, while for abnormal 
carbenes, the increased donor properties of 
the ligand may weigh out the lower C(4)–
H acidity. This situation becomes delicate 
in the mixed normal-abnormal carbene 
precursor 7 (Scheme 5), in which the in-
termediate monocarbene complex experi-
ences low palladate character due to the 
normal bonding of the carbene paired with 
the low acidity of the C(4)-bound proton. 
Based on the model sketched above, it is 
not surprising that this intermediate fails to 
cyclometallate and arrests at the monocar-
bene stage. After anion metathesis, com-
plex 8 has been isolated in good yields.
The reactivity of the dicarbene com-
plexes 5 and 6 towards Lewis acids such 
as Ag+ ions and towards Brønsted acids 
(H2SO4, H3PO4, HOAc) has revealed that 
Scheme 4.
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Scheme 5.
be a potential source for distinct stereo-
electronic effects. 
In order to unambiguously evaluate the 
electronic impact of C(4) bonding in imi-
dazolylidene ligands, we have synthesized 
the palladium complexes 9 and 10 (Fig. 
2). These complexes comprise sterically 
identical permethylated dicarbene ligands 
which bind the metal center in a normal co-
ordination mode via C(2) and abnormally 
via C(4), respectively.[25] Due to the strong 
structural analogy of the complexes, dif-
ferences in reactivity patterns may be at-
tributed to the electronic impact of normal 
vs abnormal carbene bonding exclusively, 
while stereoelectronic effects are negli-
gible.
The most substantial structural dif-
ferences between complexes 9 and 10 are 
found in the metal–halide bond lengths. The 
Pd–Cl bonds are considerably longer in the 
abnormal carbene complex 10 than in 9
(average Pd–Cl 2.404(4) Å vs. 2.357(2) Å). 
This difference illustrates the larger trans
influence of C(4)-bound carbenes.
Unique reactivity patterns have been 
identified for the abnormal carbene com-
plexes, specifically upon reaction with 
Lewis acids and in oxidative addition-re-
ductive elimination sequences. In line with 
previous studies on the reductive elimina-
tion from palladium(ii) complexes of ab-
normal carbenes,[26] reductive elimination 
of the carbene ligand is strongly promoted 
also from palladium(iv) centers. Depend-
ing on the substitution pattern on the C(5) 
position, either reductive CNHC–CNHC elimi-
nation (for H attached to C(5)) or reduc-
tive carbon–halogen elimination (for CH3
attached to C(5)) has been observed. In 
contrast, the C(2)-bound dicarbene com-
plexes are resistant towards such reductive 
elimination patterns. These reactivities as 
well as analytical investigations using X-
ray diffraction and X-ray photoelectron 
spectroscopy indicate that the C(4) bond-
ing mode increases the electron density 
at the metal center substantially, placing 
such C(4)-bound carbene ligands amongst 
the most basic neutral donors known thus 
far.[27] A direct application of this enhanced 
electron density at the metal center is dem-
onstrated by the catalytic H2 activation with 
abnormal carbene complexes under mild 
conditions, leading to a catalytic process 
for the hydrogenation of olefins. Notably, 
the normal dicarbene analogs display only 
very low hydrogenation activity.
Direct metallation of the C(2)-
protected diimidozolium salts 4 with 
RhCl3 or [RhCl(cod)]2 and KI affords 
the rhodium(iii) complexes 11 compris-
ing abnormally C(4)-bound cis-chelating 
dicarbene ligands (Scheme 6).[28] Similar 
to the palladation reaction, the presence 
of acetate ions is pivotal for success-
ful metallation with rhodium. Moreover, 
detailed analyses of the metallation us-
ing [RhCl(cod)]2 suggest that prior to 
metallation, the rhodium(i) precursor is 
oxidized in a cascade transformation in-
volving air and the iodide/iodine couple 
to rhodium(iii). Accordingly, metalla-
tion takes place with the more electro-
philic rhodium(iii) nucleus rather than 
with rhodium(i). These observations are 
consistent with the mechanism depicted 
above and do not support an oxidative 
Cimi–H bond activation process.
The complexes have been isolated as 
dimetallic species containing two (+2-I)3-
bridged rhodium(iii) centers. In the pres-
ence of coordinating solvents (e.g. CH3CN)
or exogenous ligands such as PPh3, the 
dimeric structure is cleaved to yield the 
monometallic complexes 12. Crystallo-
graphic analyses indicate a considerably 
higher trans influence of abnormal C(4)-
bound carbenes as compared to normally 
coordinating imidazolylidenes. The unique 
bonding properties have been exploited 
for developing an efficient catalytic pro-
cess for the transfer hydrogenation of ke-
tones using iPrOH as dihydrogen source. 
While typically, rhodium(i) precursors are 
used for such reactions, the exceptionally 
strong donor ability of 4-imidazolylidenes 
allows for using less oxidation-sensitive 
rhodium(iii) catalysts. When ligated by 
weaker donating C(2)-bound dicarbenes, 
the rhodium center shows negligible activ-
ity in hydrogen transfer catalysis.
Further studies indicate that C–H bond 
activation is not restricted to the highly 
activated carbinol C–H bond in iPrOH, as 
required for transfer hydrogenation. As a 
consequence of the high nucleophilicity of 
the rhodium center due to abnormal imida-
zolylidene bonding, cleavage of an unacti-
vated C
alkyl–H bond has recently been ob-
served.[29] These preliminary results may 
underpin the great potential of abnormal 
carbenes in mediating bond activation pro-
cesses under remarkably mild conditions. 
2.3 Bonding Considerations
The extraordinary high donor strength 
of C(4)-bound imidazolylidenes points to 
an increased relevance of a zwitterionic res-
onance form as opposed to a carbene-type 
resonance structure (cf. Scheme 2). A zwit-
terionic form may be energetically more fa-
vored in C(4)-bound carbenes as compared 
to C(2)-bound analogs, since the negative 
and positive formal charges are better sepa-
rated and do not both reside on the NCN 
fragment. According to this model, a C(4)-
bound imidazolylidene may be divided in a 
first approximation into an anionic vinyl C = 
C residue and an NCN amidinium cation as 
intramolecularly appended charge compen-
Fig. 2. Schematic 
representation of 
the isostructural 
complexes 9 and 10
including their crystal 
structures (ORTEPs at 
50% probability level).
 	   

   v n	 

















































 









   		
Scheme 6.
sation. Combined with the reduced inductive 
effects of the heteroatoms noted previously, 
such vinyl-type, formally anionic ligand 
bonding may rationalize the higher donor 
power of C(4)-bound imidazolylidenes as 
compared to their C(2)-bound homologs. 
While this model casts some doubt on the 
use of the term ‘carbene’, similar consid-
erations apply for carbenes derived from 
related azolium precursors such as triaz-
olylidenes and pyridylidenes, but also for 
most of the Fischer-type carbene ligands.[30]
For clarity, convenience, and consistency, 
however, the term ‘carbene’ seems most 
warranted. 
3. Abnormal Triazolylidene 
Complexes
Formation of abnormal triazolylidene 
complexes has recently been accomplished 
by using 1,2,3-triazoles as precursors for 
ligand synthesis (Scheme 7).[31] Such triaz-
ole heterocycles are accessible via a highly 
versatile 1,3-dipolar cycloaddition reaction 
of azides and acetylenes (‘click chemis-
try’, Huisgen cycloaddition), allowing for 
the introduction of a variety of function-
alities in the ligand skeleton. Methylation 
of the 1,4-disubstituted triazole 13 at the 
N(3)-position is selective and yields the 
triazolium salt 14 as precursor for abnor-
mal carbene bonding (Scheme 7). Metal-
lation of has been successfully performed
via C–H bond activation using [Pd(OAc)2]
to give the dimeric complex 15 along with 
monometallic complexes.[32]
Furthermore, reaction with Ag2O af-
fords the presumably ionic silver dicarbene 
complex 16, which is an efficient starting 
material for transmetallation reactions. 
According to this methodology, a variety 
of abnormal ruthenium(ii), iridium(i) and 
rhodium(i) complexes 17 have been ob-
tained. A preliminary assessment of the 
donor strength of these 1,2,3-triazolylidene 
ligands on the basis of iCO stretching fre-
quencies of the iridium dicarbonyl complex 
17 (Scheme 7, MXL = IrCl(CO)2) indicates 
that the triazolylidene ligand is a slightly 
better donor than the most basic normal 
carbenes. The resulting Tolman electronic 
parameter (TEP) i = 2047.4 cm–1 is lower 
than the TEP of cyclohexyl-disubstituted 
2-imidazolylidene (i = 2049.6 cm–1),[33]
yet considerably higher than the TEP of 
abnormal 4-imidazolylidenes (i = 2039 
cm–1).[20a] The electronic impact of the tri-
azolylidene ligand may be further adjusted 
by modifying the heterocycle substituents 
of the heterocycle.
4. Pyridylidene Complexes
Pyridinium salts represent a subclass 
of carbene precursors that are particularly 
useful. First, the synthetic flexibility of 
pyridine chemistry is vast and allows for 
the tailoring of the ligand for various pur-
poses. Second, formal deprotonation of a 
ring carbon gives carbenes that are stabi-
lized by only one heteroatom, irrespective 
of whether the carbene is of the normal or 
abnormal type (cf. Fig. 1). The reactivity 
of such a putative carbene is high, which 
renders complex formation via the free 
carbene route difficult. Hitherto, free pyri-
dylidenes have been characterized only in 
the gas phase by mass spectrometry.[34]
A versatile methodology to install tran-
sition metal centers on pyridinium salts 
comprises oxidative addition. Following 
pioneering work by Raubenheimer and 
coworkers,[35] we have introduced poten-
tially chelating donor groups to the pyri-
dine skeleton.[36] The corresponding bro-
mopyridine 18 may be transformed into a 
pyridylidene complex either by a classical 
reaction sequence involving first nitrogen 
quaternization and then metal insertion, 
or alternatively via oxidative addition 
and subsequent nitrogen quaternization 
(Scheme 8). 
Thus, oxidative addition of the 2-bro-
mopyridines 18 to palladium(0) yields 
the C,E-bidentate coordinating pyridyl 
palladium(ii) complexes 19, which exist 
as dimeric structures due to pyridine ni-
trogen coordination to another palladium 
center. Upon protonation, the monometal-
lic 2-pyridylidene complexes 20 form re-
versibly. Less reversible alkylation of the 
pyridine nitrogen appears to be disfavored, 
presumably due to the ortho shielding ef-
fect of the palladium fragment. Quater-
nization of 18 before metallation and 
subsequent oxidative addition of the pyri-
dinium salt 21 to Pd(dba)2 provides access 
to the pyridylidene complex 22. Notably, 
N-methylation inhibits a chelating ligand 
coordination mode, since upon chelate for-
mation, the ligand trans to the SPh donor 
group would be located in too close prox-
imity to the N-bound CH3 group. Instead, 
complex 22 exists as a one-dimensional 
polymer. 
The palladium pyridylidene complex-
es are moderately active catalysts in the 
Heck-type arylation of styrene. Mechanis-
tic studies support a heterogeneous mode 
of action, which includes the loss of the 
pyridylidene ligand from the metal coor-
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Scheme 8.
dination sphere. Such reaction trajectories 
may need to be taken into account when 
refining pyridylidene type complexes for 
cross-coupling catalysis.
5. Conclusions
Advances in transition metal-mediated 
catalysis show a remarkably good correla-
tion with the discovery and implementa-
tion of strong donor ligands. Considerable 
improvements have been achieved at dif-
ferent stages, for example when introduc-
ing aryl phosphines in the late 1950s, upon 
employing alkyl phosphines in the late 70s, 
and again with the application of C(2)-
bound imidazolylidenes at the end of the 
last millennium as ligands to the catalyti-
cally active metal center. All experimental 
and theoretical evidence now suggests that 
abnormal carbenes are even stronger li-
gands, surpassing the donor properties of 
the popular, highly heteroatom-stabilized 
2-imidazolylidenes substantially. We have 
started to use these unique ligand proper-
ties by developing first catalytic applica-
tions where electron-rich metal centers 
play a key role, such as in H–H and C–H 
bond activation. When taking into account 
the vast possibilities for ligand tuning, ab-
normal carbenes have great potential for 
catalytically activating unreactive bonds 
under mild conditions. 
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